5-羟甲基胞嘧啶
癌症
癌症治疗
医学
生物
计算生物学
肿瘤科
基因表达
内科学
DNA甲基化
基因
遗传学
作者
Aparna Vasanthakumar,Lucy A. Godley
出处
期刊:Cancer genetics
[Elsevier BV]
日期:2015-03-02
卷期号:208 (5): 167-177
被引量:117
标识
DOI:10.1016/j.cancergen.2015.02.009
摘要
Emerging data have demonstrated that 5-methylcytosine (5-mC) and its oxidized products 5-hydroxymethylcytosine (5-hmC), 5-formylcytosine (5-fC), and 5-carboxylcytosine (5-CaC) play unique roles in several biological processes, including the control of gene expression and in the pathogenesis of cancer. In this review, we focus on 5-hmC and the disruption of its distribution in several cancers, including hematological malignancies and solid tumors. We present an outline of how 5-hmC is closely associated with metabolic pathways and may be the missing link connecting epigenetics with metabolism in the context of cancer cells. Finally, we discuss the diagnostic and prognostic importance of 5-mC and 5-hmC patterning, and how we may be able to establish new paradigms in cancer therapy based on these alterations.
科研通智能强力驱动
Strongly Powered by AbleSci AI